BBIO geopolitical news & exposure
BBIO geopolitical news and exposure. BBIO appears in 230 Geopolitics Alpha notes. The newest is 30 Sep 2026, 16:22 UTC. Stored price-reaction rows cover 0 of those notes.
- Bristol Myers trial revisions shake confidence in new class of fibrosis drugs
30 Sep 2026, 16:22 UTC
- FDA starts review of Roche’s multiple sclerosis pill
30 Sep 2026, 15:54 UTC
- Abbott launches Freenome’s colorectal cancer screening test
30 Sep 2026, 14:58 UTC
- Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.
30 Sep 2026, 14:32 UTC
- Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
30 Sep 2026, 14:15 UTC
- FDA Launches Nationwide Effort to Expand Scientific Expertise and Consumer Voices to Advisory Committees
30 Sep 2026, 13:26 UTC
- Most powerful obesity drug yet: People lost up to 25% of weight in trial
29 Sep 2026, 22:30 UTC
- FDA Investigation Leads to Charges Against Two Indian Nationals Involved in Transnational Counterfeit Drug Distribution Scheme
29 Sep 2026, 21:01 UTC
- After losing his voice to cancer, this founder is building “glasses for voice”
29 Sep 2026, 15:00 UTC
- RFK Jr’s food policy priorities need more resources to implement, FDA nominee says
29 Sep 2026, 13:49 UTC
- RFK’s food policy priorities need more resources to implement, FDA nominee says
29 Sep 2026, 13:49 UTC
- AstraZeneca invests $2B in Summit, gaining ‘seat at the table’ for PD-1/VEGF drug push
29 Sep 2026, 12:49 UTC
- FDA Approves First Treatment for MCT8 Deficiency
28 Sep 2026, 21:43 UTC
- FDA intends to evaluate changes to the PMTA regulatory framework
28 Sep 2026, 21:00 UTC
- To keep drug prices high, pharma has been piling up the patents
28 Sep 2026, 19:53 UTC
- FDA issues draft guidance for surgical robots
28 Sep 2026, 15:34 UTC
- Merck, Daiichi end plans to seek speedy approval of lung cancer ADC
28 Sep 2026, 12:52 UTC
- The Next Evolution of TLIF: Where Innovation Meets Clinical Evidence
28 Sep 2026, 09:00 UTC
- Genmab Eyes Three Pivotal Phase III Cancer Readouts in Q4
27 Sep 2026, 00:01 UTC
- Generic Drug User Fee Amendments
25 Sep 2026, 23:34 UTC
- Can Trump ever be wrong? His pick to lead FDA refused to say.
25 Sep 2026, 23:00 UTC
- Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act
25 Sep 2026, 21:36 UTC
- What's New Related to Drugs
25 Sep 2026, 21:33 UTC
- Candy Power For Man may be harmful due to hidden ingredient
25 Sep 2026, 21:32 UTC
- Miracle Power of King Kong Honey may be harmful due to hidden ingredient
25 Sep 2026, 21:31 UTC
- Public Notification: Vital Honey contains hidden drug ingredient
25 Sep 2026, 21:27 UTC
- Novel Drug Approvals for 2026
25 Sep 2026, 21:24 UTC
- Notable Approvals | Drugs
25 Sep 2026, 18:48 UTC
- FDA Approves Third Treatment for Fibrodysplasia Ossificans Progressiva
25 Sep 2026, 18:46 UTC
- Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s data
25 Sep 2026, 13:21 UTC
- Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s
25 Sep 2026, 11:00 UTC
- NIH funding cuts delayed a promising childhood brain cancer trial. Patients lost time they didn't have.
25 Sep 2026, 11:00 UTC
- Pharma stock soars 150% on injectables deal with Wegovy maker Novo
25 Sep 2026, 09:58 UTC
- After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring
25 Sep 2026, 09:11 UTC
- RNAi drug specialist ADARx raises $446M IPO
25 Sep 2026, 00:36 UTC
- Grail multicancer detection test wins FDA advisers’ backing
24 Sep 2026, 21:08 UTC
- FDA nominee Overton parries vaccine questions at Senate hearing
24 Sep 2026, 20:46 UTC
- Merck reveals study success, and possible safety worries, for eye drug hopeful
24 Sep 2026, 15:34 UTC
- Lilly’s latest China drug deal; Immunovant’s setback in lupus
24 Sep 2026, 14:14 UTC
- Oppenheimer Initiates Coverage of Pacira BioSciences with Outperform
24 Sep 2026, 07:36 UTC